Obstructive Sleep Apnea Hypopnea Syndrome and Pulmonary Embolism： Warfarin Versus Positive Airway Pressure as Determinant

作     者：Filipa Ramalho Fernandes Dulce Apolinario Antonio M Esquinas Fernandes Filipa Ramalho;Apolinário Dulce;Esquinas Antonio M

作者机构：Department of Pneumoloqv Unidade Local de Saude da Guarda EPE - Sousa Martins Hospital Guarda Portugal Department of Pneumology Centro Hospitalar de Tras-os-Montes e Alto Douro EPE - Sao Pedro de Vila Real Hospital Vila Real Portugal Intensive Care and Non Invasive Ventilatory Unit Hospital Morales Meseguer Murcia Spain 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2016年第129卷第2期

页      面：251-252页

核心收录：

学科分类：090603[农学-临床兽医学] 0831[工学-生物医学工程（可授工学、理学、医学学位）] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 08[工学] 09[农学] 0906[农学-兽医学] 10[医学] 

主　　题：肺栓塞 华法林 基因 内皮缩血管肽类 睡眠呼吸暂停 阻塞性 睡眠呼吸暂停综合征 综合征 

摘      要：To the Editor： Xie et al, analyzed warfarin doses in pulmonary embolism （PE） and its adverse effects in patients with obstructive sleep apnea hypopnea syndrome （OSAHS）. The key findings were that OSAHS patients required a significantly higher dose of warfarin than their non-OSAHS counterparts （4.73 mg vs. 3.61 mg, P 〈 0.001） and that PE recurrence was higher in OSAHS than in non-OSAHS groups after withdrawal ofwarfarin （21.43% vs. 6.78%, P = 0.047）.